Cleared Traditional

K063771 - GLUCOCARD X-METER BLOOD GLUCOSE MONITORING SYSTEM

K063771 is an FDA 510(k) clearance for GLUCOCARD X-METER BLOOD GLUCOSE MONITOR..., manufactured by Arkray Factory USA, Inc.. The device is a Class 2 Chemistry device with product code NBW cleared through the Traditional 510(k) pathway after a 231-day FDA review.

K063771 · Arkray Factory USA, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2007
Decision
231d
Days
Class 2
Risk

K063771 is an FDA 510(k) clearance for the GLUCOCARD X-METER BLOOD GLUCOSE MONITORING SYSTEM. Classified as System, Test, Blood Glucose, Over The Counter (product code NBW), Class II - Special Controls.

Submitted by Arkray Factory USA, Inc. (Edina, US). The FDA issued a Cleared decision on August 9, 2007 after a review of 231 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1345 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Arkray Factory USA, Inc. devices

FDA 510(k) Submission Details - K063771

510(k) Number K063771 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 21, 2006
Decision Date August 09, 2007
Days to Decision 231 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
143d slower than avg
Panel avg: 88d · This submission: 231d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

NBW Device Classification - Class 2, Special Controls

Product Code NBW System, Test, Blood Glucose, Over The Counter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1345
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - NBW System, Test, Blood Glucose, Over The Counter

All 310
Devices cleared under the same product code (NBW) and FDA review panel - the closest regulatory comparables to K063771.
ADVOCATE REDI-CODE BLOOD GLUCOSE MONITORING SYSTEM, MODELS TD-4223E
K072039 · Taidoc Technology Corporation · Oct 2007
REVOLUTION TD-4229 BLOOD GLUCOSE MONITORING SYSTEM
K072489 · Taidoc Technology Corporation · Sep 2007
PTS PANELS CHOL+HDL+GLU PANEL TEST STRIPS
K071507 · Polymer Technology Systems, Inc. · Sep 2007
CLEVER CHEK HEALTH CARE SYSTEM SOFTWARE, VERSION 1.0
K070941 · Taidoc Technology Corporation · Jun 2007
NOVA MAX BLOOD GLUCOSE MONITOR SYSTEM, 90001,90002
K070255 · Nova Biomedical Corp. · Jun 2007
ACCU-CHEK PERFORMA SYSTEM
K070585 · Roche Diagnostics Corp. · May 2007